References
Höfle, G. et al. Angew. Chem. Int. Ed. Engl. 35, 1567–1569 (1996).
Bollag, D. M. et al. Cancer Res. 55, 2325–2333 (1995).
Horwitz, S. B. Nature 367, 593–594 (1994).
Wessjohann, L. Angew. Chem. Int. Ed. Engl. 36, 715–718 (1997).
Nicolaou, K. C. et al. Nature 387, 268–272 (1997).
Haar, E. T. et al. Biochemistry 35, 243–250 (1996).
Hung, D. T., Chen, J. & Schreiber, S. L. Chem. Biol. 3, 287–293 (1996).
Grubbs, R. H., Miller, S. J. & Fu, G. C. Acc. Chem. Res. 28, 446–452 (1995).
Su, D.-S. et al. Angew. Chem. Int. Ed. Engl. 36, 757–759 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cowden, C. Cancer drugs better than taxol?. Nature 387, 238–239 (1997). https://doi.org/10.1038/387238a0
Issue Date:
DOI: https://doi.org/10.1038/387238a0
- Springer Nature Limited
This article is cited by
-
Molecular dynamics simulation and density functional theory studies on the active pocket for the binding of paclitaxel to tubulin
Journal of Molecular Modeling (2012)
-
A new cytotoxic spiroketal from the myxobacterium Sorangium cellulosum
Archives of Pharmacal Research (2009)
-
Biodiversity, traditional medicine and public health: where do they meet?
Journal of Ethnobiology and Ethnomedicine (2007)
-
Tubulin interacting agents: Novel taxanes and epothilones
Current Oncology Reports (2003)
-
Ringing the changes
Nature (1997)